INTRODUCTION
The sleep apnea and hypopnea syndrome (SAHS) is a disorder affecting 2%-4% of the adult population 1 . Nasal continuous positive airway pressure (CPAP) is the most effective treatment in SAHS symptomatic patients [2] [3] [4] [5] [6] .
Standard practice for CPAP treatment requires pressure titration during an attended laboratory polysomnography. The aim of this procedure is to identify an effective pressure to remove apneas, hypopneas, snoring and arousals. However, polysomnographic titration is expensive and time-consuming. Autoadjusted titration with autoCPAP devices has been proposed 7 to overcome these disadvantages. These devices monitor one or more of the following parameters -snoring, flow or impedancein order to detect respiratory events and adjust the CPAP pressure. They also calculate the optimal pressure automatically. To date, only autoCPAP titration by standard laboratory polysomnography has been recommended 8 given that very few studies [9] [10] [11] [12] [13] have been carried out in unattended conditions, yielding contradictory results in CPAPnaive patients 11 .
The prediction of CPAP pressure using a formula which includes the apnea-hypopnea index (AHI) and the anthropometrical parameters has been proposed 14 . This could also be used to simplify conventional CPAP titration 15, 16 . A randomized crossover controlled study on 18 CPAP-naïve patients demonstrated that the efficacy of a predicted formula titration with at-home self-adjustment was similar to that of standard titration 17 .
Additionally, a non-randomized study 18 found a similar clinical improvement and CPAP adherence between predicted formula and standard titration groups. Therefore, if unattended autoadjusted or predicted formula CPAP titration is performed, considerable savings in cost and significant reductions in the waiting lists could be achieved worldwide.
The aim of this study was to ascertain, in a large sample of CPAP-naive patients, whether CPAP titration performed with an unattended domiciliary autoadjusted CPAP device or with a predicted formula was as effective as CPAP titration carried out by full polysomnography. The main outcomes were the apnea-hypopnea index and the subjective daytime sleepiness after fixed CPAP treatment. Thus, we ascertained whether these methods were alternatives to the conventional CPAP titration. Some of the results of this study have been reported in the form of an abstract 19 .
METHODS

Study design
This randomized controlled clinical trial included two test groups (autoadjusted and predicted formula titration) and one control group (standard titration). In order to determine differences in the main outcomes between groups, we used a power of 0.8
and an alpha error of 0.05. The study was open to the researchers and blinded to the technicians who set the questionnaires and analyzed the polysomnographies.
Patients
Patients requiring CPAP treatment -AHI 30 and relevant daytime subjective sleepiness 20 (Epworth sleepiness scale 12)-aged between 18-70 years were consecutively recruited from 10 sleep centers in Spain. The exclusion criteria were as follows: psychophysical incapacity to perform questionnaires, patients with chronic disease (cancer, chronic pain, renal failure, moderate or severe chronic obstructive pulmonary disease etc), drugs or alcohol addiction, Cheyne-Stokes syndrome, lifethreatening SAHS, patients with previous uvulopalatopharyngoplasty (UPPP), absence of a partner at home, important chronic nasal obstruction, lack of skill in adjusting the nasal mask in a daytime CPAP trial (see protocol) and refusal to participate in the study.
Three hundred and sixty patients (120 patients per group) were finally included.
Study protocol
Patients with suspicion of SAHS were referred for conventional polysomnography. The baseline and CPAP polysomnographic studies were analyzed manually, at each participating center, according to standard criteria 21, 22 20 . After the baseline conventional polysomnography, a 20 minute daytime CPAP trial was carried out only if the patient met the inclusion and exclusion criteria.
The patients were also excluded when a significant nasal obstruction or a lack of skill in adjusting the nasal mask was detected during this CPAP trial. Once the patients were included, they were randomized into one of the 3 study groups (Figure 1 ).
Each center received written instructions from the coordinating center to carry out the study. This document standardized the questionnaires; the 20 minutes of CPAP trial; the information about the study and CPAP treatment for the patients; the three types of titration (standard, autoadjusted and predicted formula); the list of the excluded and abandoned cases and secondary effects; the informed consent and the visual analogical scale. The recommendations to perform the Epworth scale and the quality of life scales were also included in these guidelines while maintaining the specific recommendations of the authors. Patient inclusion was competitive at the centers. The inclusion period finished when the total number of patients included were 360. To avoid imbalance, each center could include up to 45 patients.
The data collection was performed in a home-designed electronic data base available at each center. To minimize potential errors, the arithmetical calculation, prediction formula and quality of life scales were automated. At the end of the study each center e-mailed the data (in Excel format) generated automatically by the software. All the data files were assembled together in one table to perform the final analysis at the coordinating center in Cáceres.
Standard titration
The patients included in this group underwent a second polysomnography for manual CPAP titration. The starting pressure was 4 cm H 2 O and the pressure was increased by 1 cm H 2 O every five minutes until the apneas disappeared. Thereafter, the pressure was increased by 1 cm H 2 O every ten minutes until the hypopneas, flow limitation and snoring disappeared. This last pressure was considered to be the optimal pressure.
Autoadjusted titration
The patients received information on the autoCPAP and slept at home with the device 
Predicted formula titration
The optimal pressure was estimated by an equation already published 14 
Follow-up and outcomes
Once the optimal pressure was achieved, treatment was initiated with a fixed level of CPAP at home. Not all the centers had the same CPAP devices but a manometer was used to check the pressure level in all the patients. The patients were evaluated on four occasions (figure 1). The second and third visits were used to increase the CPAP pressure in the predicted formula group, and to try to alleviate the possible secondary effects in all the groups. After 12 weeks all patients underwent a new polysomnography with CPAP. The optimal pressure obtained in the initial titration was maintained throughout the night.
The main outcomes were the AHI and the Epworth sleepiness scale. The study was approved by the ethics committees of the 10 centers. Informed consent was obtained from all the patients.
Inter-observer agreement on autoadjusted titration
Prior to the study, one researcher from each center underwent a short period of training based on 5 representative "Raw Data" graphics from the Autoset T. The training was carried out in order to become acquainted with the visual analysis of the pressure. At the end of the investigation, we undertook another study to evaluate the inter-observer agreement in the visual calculation of CPAP pressure (see Supplement).
Statistical analysis
We compared the characteristics of the three groups at baseline (before therapy) and CPAP pressure and use at the end of the study (after therapy) by one way ANOVA for continuous variables. Where appropriate, differences between individual means were tested using the LSD (least significant difference) (SPSS 11.0, SPSS inc, Chicago A p-value of <0.05 was considered to be statistically significant.
RESULTS
A hundred and six patients (23%) out of the 466 initially evaluated were excluded for the following reasons: chronic disease 40 (37.7%), severe nasal obstruction 13 (12.3%), refusal to participate in the study protocol 12 (11.3%), psychophysical incapacity to answer the questionnaires 10 (9.4%), absence of partner at home 10 (9.4%), alcohol addiction 9 (8.5%), previous UPPP 6 (5.7%), lack of skill in adjusting the nasal mask 5 (4.7%) and life-threatening SAHS 1 (0.9%).
The number of patients per center varied according to the competitive nature of the inclusion: four centers included 45 patients, one 39, one 37, two 33, one 31 and one included 7. No inter-center differences were found in the main and secondary outcomes.
Out of 360 patients finally included, 45 (12.5%) abandoned the study (Table 1) . No differences were found in the percentages of withdrawal between the standard (15.1%), the autoadjusted (10.9%) and predicted formula groups (11.3%). Likewise, there were no significant differences in the titration failures between the standard (2.4%) and the autoadjusted groups (4.2%).
The autoadjusted titration at home was achieved on the first attempt in 98 patients out of the 119 patients initially included. It was repeated once in 21 patients and twice in 11
patients. Titration failed in 5 patients. The reasons for these 32 repeated titrations were excessive leakage in 20 cases and a registration period under 6 hours or a sleep time under five hours (subjectively appreciated by the patient) in the remaining12 cases.
In the predicted formula titration group, CPAP pressure was increased during the The general characteristics of the population finally studied are shown in Table 2 . No statistical differences were observed in the three study groups.
The Epworth Sleepiness Scale and the polysomnographic variables (AHI, arousal index, percentages of sleep periods and oxygen saturation) showed a similar statistical improvement after CPAP treatment in all the groups ( Table 3 ). The AHI under CPAP treatment was slightly higher in the predicted formula group.
The final CPAP pressure was lower (8.4±1) in the predicted formula group than in the other two groups: standard (8.8±1.9) and autoadjusted (9.1±1.9), although there were statistically significant differences only between autoadjusted and predicted formula groups. There were no statistical differences in the CPAP compliance between groups.
All the quality of life tests improved after treatment in all the groups (Table 4 ). In the autoadjusted group the degree of improvement in SF 36 physical and EuroQol was lower than that observed in the standard group. The quality of life scores at baseline were higher in the autoadjusted group than in the standard group (see discussion for details). In the predicted formula group the level of improvement in the quality of life tests was similar to that obtained in the standard group.
As regards the secondary effects (Table 5) , there were no important differences between the standard and the other groups. Nevertheless, there was a tendency for the autoadjusted group to present more side effects.
DISCUSSION
This is the first randomized controlled study that determines whether autoadjusted CPAP titration at home or a predicted formula CPAP titration is an alternative to standard CPAP titration in a large sample of CPAP-naïve patients. This study suggests that these alternative titration methods improve the clinical symptoms and the polysomnographic parameters, whilst maintaining adherence, use of treatment and frequency of secondary effects similar to those obtained with the standard method.
A number of studies have shown that some autoCPAP devices are effective in obtaining optimal CPAP pressure [28] [29] [30] , but only a few of these studies have centered on the efficacy of autoCPAP titration in unattended conditions and CPAP-naive patients. As for the AHI, some clinical series have yielded acceptable results 9,10,11,13 . One randomized controlled study 12 showed that the improvement in sleepiness and the CPAP acceptance resembled that obtained by conventional titration despite the fact that no sleep studies were performed during the follow-up period to determine the AHI. Our study confirms the results of the clinical series 9,10,13 with the addition of an improvement in the polysomnographic variables.
Series et al 9 analyzed autoCPAP recordings, after one or two weeks of domiciliary CPAP use, to determine the optimal pressure. We obtained effective autoCPAP titration at home using only one night in 82% of the patients. Two additional nights were performed with the patients that failed during the first night. As a consequence, optimum CPAP pressure was obtained in 96% of all subjects in the autoadjusted group.
This has important economic and practical implications given that the number of patients that can be titrated at home with one device is higher with our methodology.
One of the arguments against autoadjusted CPAP titration is that the oxygenation level is not measured 8 . Our patients, in the autoadjusted titration group, suffered from significant oxygen desaturation in the baseline study. However, after CPAP treatment, the oxygenation parameters were similar to those of the standard titration group.
Therefore, this finding challenges the need for measuring oxygen saturation during autoCPAP titration.
We used a specific autoCPAP device, the Autoset-T. This device monitors changes in airflow into the mask and monitors snoring. It responds to apneas, flow limitation and snoring. Given that different autoCPAP devices monitor diverse parameters, the results of this study should not be extrapolated to other devices 31, 32 .
To date, the main aim of the CPAP treatment has been to improve the clinical symptoms and to normalize the physiological variables in polysomnography. In our study, the improvement in symptoms such as sleepiness, arousal index, oxygen saturation, and the AHI was very similar in all the groups, although the predicted formula group had a higher number of residual apneas and hypopneas (table 3) . A number of well designed studies have shown that the AHI is an independent factor of cardiovascular risk [33] [34] [35] and traffic accidents [36] [37] [38] , but long term implications of residual apneas and hypopneas after CPAP treatment have not been established.
The optimal CPAP pressure in the predicted formula group has been calculated by a published equation (see methods). Whenever the pressure was >9 cm H 2 O, it was initially set at 9 and home adjustment was carried out to achieve a better individual adaptation to high CPAP pressures. The mean pressure after domiciliary adjustment higher than our final CPAP pressure in the predicted formula group probably because of differences in the methodology employed. Therefore, given our trend towards a higher residual AHI in the formula group, the possibility of refining our methodology could be considered, although a higher pressure could lead to more secondary effects and perhaps consequences in adherence and compliance of the treatment.
Most of the quality of life tests showed less improvement in the autoadjusted group than in the standard group (table 4) probably because baseline quality of life tests were better in the autoadjusted group. Moreover, the less specific quality of life tests showed fewer improvements.
Out of the 466 patients initially included in the study, 45 dropped out during the study and 106 were excluded. The main reason for exclusion was the presence of disorders preventing the evaluation of the quality of life.
The study was open to the researchers and blinded to the technicians who set the questionnaires and analyzed the polysomnographies. This could have introduced a potential bias. However, a bias is highly unlikely given that the study was carried out at 10 centers, and given that most of the questionnaires of the study were self-administered and that information to the patients about the CPAP treatment was standardized.
In conclusion, the results of this study suggest that CPAP titration can be performed with a home-autoadjusted CPAP device or with a predicted formula with domiciliary adjustment. Full polysomnography is not the only method that can adequately adjust the CPAP pressure. (figure 2). These procedures could lead to considerable savings in cost and to significant reductions in the waiting lists.
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FIGURE LEGENDS
The aim of this study was to determine the inter-observer variability, analyzing the optimal visual pressure (percentile 90) using AutoSet T raw data ("view night profile").
At the end of the study, each center randomly chose two raw data graphs from the AutoSet T which had been included in the study (see Methods). The 20 graphs collected were sent to each center by e mail in electronic format. The researcher, who dealt with the estimation of the optimal pressure during the study, also evaluated the new "view night pressure profiles". As in the study, the measurements of pressure were made by all the units. The measurements of the 20 graphs were sent to the coordinating center A very small inter-observer variability was observed in the calculation of the visual pressure of CPAP (percentile 90) with the result that this variability had no negative influence on our results.
